| Application no. and date | 20209166.6 (espacenet) (Federated) (European Patent Register), 20171215 | | Patent/reg. no. and date | DK/EP 3851441, 20230628 | | Publication date | 20210721 | | Priority no. and date | US 201662434836 P, 20161215 | | EP pub. no. and date |
EP 3851441 20210721 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | | | Inventor | CRAVILLION, Theresa, c/o Genentech Inc.
1 DNA WAY
South San Francisco, CA 94080, US,
GOSSELIN, Francis, c/o Genentech Inc.
1 DNA WAY
South San Francisco, CA 94080, US,
Han, Chong, c/o Genentech Inc.
1 DNA Way
South San Francisco, CA 94080, US,
KELLY, Sean M., c/o Genentech Inc.
1 DNA Way
South San Francisco, CA 94080, US,
SAVAGE, Scott, 545 Middlefiled Road Suite 208
Menlo Park, CA 94025, US | | Representative | | | Opponent | | | IPC Class | C07D 498/04 (2006.01) | | Title | PROCESS FOR THE PREPARATION OF (S)-2-((2-((S)-4-(DIFLUOROMETHYL)-2-OXOOXAZOLIDIN-3-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)AMINO) PROPANAMIDE | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
